1337596-05-0Relevant articles and documents
BENZONAPHTHYRIDINAMINES AS AUTOTAXIN INHIBITORS
-
Paragraph 0226; 0228, (2013/03/26)
The present invention relates to benzonaphthyridinamines of the formula (I) as autotaxin inhibitors and to the use thereof in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in which the inhibition, regulation and/or modulation of phosphodiesterase or lysophospholipase autotaxin plays a role, in particular of various types of cancer and autoimmune and inflammatory diseases.